Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
19
2023
Washington State Finalizes Chemical in Product Restrictions; Announces Next Targets Beveridge & Diamond PC
Jun
18
2023
FDA Publishes Notice About FOP Labeling Consumer Research Keller and Heckman LLP
Jun
18
2023
ECHA Adds Two Chemicals to Candidate List of SVHCs Bergeson & Campbell, P.C.
Jun
16
2023
Second Circuit Assesses Propriety of Third-Party Releases in Purdue McDermott Will & Emery
Jun
16
2023
EPA Proposes to Ban Most Uses of PCE and Establish a WCCP for Uses Not Prohibited Bergeson & Campbell, P.C.
Jun
16
2023
Wow: Alabama Commission Pauses Medical Cannabis License Awards Bradley Arant Boult Cummings LLP
Jun
16
2023
NEWMOA Releases First-of-its-kind PFAS Regional Draft Model Legislation for Public Comment Nelson Mullins
Jun
16
2023
Privacy Tip #364 – Montana Enacts Genetic Information Privacy Law Robinson & Cole LLP
Jun
16
2023
DOJ Continues to Discuss Updates to Compliance Program Guidance and Corporate Enforcement Policies Sheppard, Mullin, Richter & Hampton LLP
Jun
16
2023
EPA Will Propose SNURs for 18 Chemicals Made from Plastic Waste-Derived Feedstocks Bergeson & Campbell, P.C.
Jun
16
2023
This Week in 340B: June 6 – 12, 2023 McDermott Will & Emery
Jun
16
2023
FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals Sheppard, Mullin, Richter & Hampton LLP
Jun
15
2023
DPR Issues Notice on Pesticide Program Annual Processing Timelines Bergeson & Campbell, P.C.
Jun
15
2023
Congressional Hearing Seeks Ways to Promote Competition in Meat Industry Keller and Heckman LLP
Jun
15
2023
Access to Abortion Pill on the Precipice: A Deep Dive into the Federal Court Rulings that will Decide the Fate of Mifepristone Sheppard, Mullin, Richter & Hampton LLP
Jun
15
2023
Pharmacy Benefit Managers are on the Federal Government’s Radar: Senate, House, and Agency Proposals Seek to Increase PBM Oversight - Part 2 Mintz
Jun
15
2023
Trending in Telehealth: June 6 – 12, 2023 McDermott Will & Emery
Jun
15
2023
Vax Requirement Sacked in TN: Medicare Providers Lose Exemption from COVID-19 Laws Bradley Arant Boult Cummings LLP
Jun
14
2023
FDA Issues Proposed Rule for Standardized and Accessible Patient Medication Information Sheppard, Mullin, Richter & Hampton LLP
Jun
14
2023
The Supreme Court’s SuperValu Decision on the “Knowingly” Element in the False Claims Act: Protecting Against Liability When There is Regulatory Ambiguity Mintz
Jun
14
2023
Minnesota Will Require Manufacturers to Report Intentionally Added PFAS and Will Ban Intentionally Added PFAS in Certain Product Categories Beginning January 1, 2025 Bergeson & Campbell, P.C.
Jun
14
2023
Healthier Choices Management Corp. v. Philip Morris USA, Inc. No. 22-1268 (Fed. Cir. Apr. 12, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jun
14
2023
New York Landlords May Get Stuck with the Bill for Unlicensed Cannabis Sticker Shops Sheppard, Mullin, Richter & Hampton LLP
Jun
13
2023
Don’t Forget Deception: FTC and Biometrics Sheppard, Mullin, Richter & Hampton LLP
Jun
13
2023
Food and Chemicals Unpacked: Pit Stop at Chevron: Will We See a Difference in Deference? [PODCAST] Keller and Heckman LLP
Jun
13
2023
Behavioral Health Law Ledger | June 2023 Greenberg Traurig, LLP
Jun
13
2023
FDA Issues Draft Guidance to Reduce Microbial Contamination in Tattoo Inks Keller and Heckman LLP
Jun
13
2023
Nano4EARTH Will Hold a Roundtable Discussion on Coatings, Lubricants, Membranes, and Other Interface Technologies on July 6, 2023 Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins